Free Trial

Synergy CHC (SNYR) Competitors

Synergy CHC logo
$3.79 -0.18 (-4.53%)
As of 07/25/2025 04:00 PM Eastern

SNYR vs. GNLX, ATOS, KRRO, ACTU, IOBT, TARA, BHST, CLLS, SKYE, and INKT

Should you be buying Synergy CHC stock or one of its competitors? The main competitors of Synergy CHC include Genelux (GNLX), Atossa Genetics (ATOS), Korro Bio (KRRO), Actuate Therapeutics (ACTU), IO Biotech (IOBT), Protara Therapeutics (TARA), BioHarvest Sciences (BHST), Cellectis (CLLS), Skye Bioscience (SKYE), and MiNK Therapeutics (INKT). These companies are all part of the "pharmaceutical products" industry.

Synergy CHC vs. Its Competitors

Synergy CHC (NASDAQ:SNYR) and Genelux (NASDAQ:GNLX) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Synergy CHC currently has a consensus target price of $10.00, suggesting a potential upside of 163.85%. Genelux has a consensus target price of $17.75, suggesting a potential upside of 431.44%. Given Genelux's higher probable upside, analysts plainly believe Genelux is more favorable than Synergy CHC.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Synergy CHC
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50
Genelux
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

In the previous week, Genelux had 1 more articles in the media than Synergy CHC. MarketBeat recorded 2 mentions for Genelux and 1 mentions for Synergy CHC. Synergy CHC's average media sentiment score of 1.89 beat Genelux's score of 0.94 indicating that Synergy CHC is being referred to more favorably in the media.

Company Overall Sentiment
Synergy CHC Very Positive
Genelux Positive

Synergy CHC has higher revenue and earnings than Genelux.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Synergy CHC$34.83M1.00$2.12MN/AN/A
Genelux$10K12,611.84-$29.87M-$0.88-3.80

37.3% of Genelux shares are held by institutional investors. 56.6% of Synergy CHC shares are held by insiders. Comparatively, 9.3% of Genelux shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Synergy CHC's return on equity of -8.48% beat Genelux's return on equity.

Company Net Margins Return on Equity Return on Assets
Synergy CHCN/A -8.48% 12.75%
Genelux N/A -93.04%-74.17%

Summary

Synergy CHC beats Genelux on 7 of the 12 factors compared between the two stocks.

Get Synergy CHC News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNYR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNYR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNYR vs. The Competition

MetricSynergy CHCCONS PD IndustryStaples SectorNASDAQ Exchange
Market Cap$36.50M$33.37B$16.19B$9.50B
Dividend YieldN/A2.53%3.14%4.01%
P/E RatioN/A32.5520.1020.05
Price / Sales1.001.8545.6789.38
Price / Cash14.9316.8715.0258.56
Price / Book-1.988.596.135.87
Net Income$2.12M$1.19B$691.82M$258.55M
7 Day Performance4.99%3.90%28.39%3.73%
1 Month Performance51.60%7.62%3.96%11.75%
1 Year PerformanceN/A-2.55%1.95%18.03%

Synergy CHC Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNYR
Synergy CHC
4.0745 of 5 stars
$3.79
-4.5%
$10.00
+163.9%
N/A$36.50M$34.83M0.0040Positive News
Gap Down
GNLX
Genelux
1.2346 of 5 stars
$3.25
-3.8%
$17.75
+446.2%
+74.0%$122.64MN/A-3.6910Analyst Forecast
Gap Up
ATOS
Atossa Genetics
3.0319 of 5 stars
$0.94
-0.1%
$6.17
+558.8%
-40.4%$120.77MN/A-4.458News Coverage
Positive News
KRRO
Korro Bio
1.7879 of 5 stars
$12.85
-1.0%
$102.43
+697.4%
-69.4%$120.57M$2.27M-1.3670News Coverage
Analyst Forecast
ACTU
Actuate Therapeutics
2.252 of 5 stars
$6.15
-0.9%
$20.50
+233.6%
N/A$120.57MN/A0.0010News Coverage
IOBT
IO Biotech
3.7887 of 5 stars
$1.79
+5.1%
$9.33
+422.6%
+53.7%$118.26MN/A-1.2030News Coverage
Positive News
Gap Up
TARA
Protara Therapeutics
2.1594 of 5 stars
$3.07
-3.0%
$20.50
+568.8%
+45.4%$118.25MN/A-1.7830
BHST
BioHarvest Sciences
N/A$7.05
flat
$13.67
+93.9%
N/A$115.80M$27.70M-14.10N/ANews Coverage
CLLS
Cellectis
3.1138 of 5 stars
$2.06
-4.2%
$4.00
+94.2%
+22.9%$114.50M$49.22M-2.40290Positive News
Gap Up
SKYE
Skye Bioscience
2.5361 of 5 stars
$3.70
-6.0%
$16.60
+349.3%
-33.7%$114.45MN/A-4.5111News Coverage
Gap Up
INKT
MiNK Therapeutics
2.8426 of 5 stars
$28.66
-29.4%
$37.50
+30.9%
+99.6%$114MN/A-11.3530Positive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:SNYR) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners